Meningococcal B (MenB)
Meningococcal B Vaccine (Bexsero/Trumenba)
Platform: Recombinant multicomponent
Vaccine that protects against meningococcal serogroup B, a leading cause of bacterial meningitis in adolescents and young adults.
Immunology Sections
Curated section analysis in progress
Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.
Wikipedia Overview
Full article ↗
Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. The vaccine is also recommended to premature infants and people with poor immune function such as from HIV/AIDS. It is also recommended that health-care workers be vaccinated. In healthy people, routine immunization results in more than 95% of people being protected.
PubMed Literature
Search PubMed ↗No PubMed results retrieved.
Semantic Scholar
Search S2 ↗No Semantic Scholar results retrieved.